An interventional study of Cemented K-wire Fixation and Plating in Closed Fracture of Finger and Finger Fracture Open, sponsored by The Second Hospital of Qinhuangdao. Completed at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-01-25.
Sponsored by The Second Hospital of Qinhuangdao · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Fractures, Bone with a site in China — 4 open to participants now, 5 under way, none of them phase 3. Fractures, Bone · China.
Among the 23 studies in Fractures, Bone with a site in China, this one is the 6th largest by enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2011, is one of 11 with no phase, and was the 11th registered.
725 studies on the registry are indexed under Fractures, Bone; 116 are open to participants now.
Browse Fractures, Bone studies →4 of the 23 studies in Fractures, Bone with a site in China are open now. Recruiting first, the newest first:
Nanjing First Hospital, Nanjing Medical University · Sites in China
Ages 18–65
Capital Medical University · Sites in China
Ages 18–100
Hebei Medical University Third Hospital · Sites in China
Ages 17+ · Healthy volunteers
Peking Union Medical College Hospital · Sites in China
Ages 50+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 72 Fractures, Bone studies recruiting now, 36 (50%) set no upper age limit and 22 (31%) stop at 75 or younger; 17 take children under 18; 14 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 3 · Phase 4 4
First in 2003; this study’s year is marked. 2 started in 2011.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 131 is above the median of 80 across 458 interventional studies indexed under Fractures, Bone.
Median enrollment 86 across the 20 interventional studies, 800 across the 3 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 23 have an industry lead sponsor. The 10 most frequent:
The Second Hospital of Qinhuangdao is the lead sponsor of 11 studies on the registry; none are open to participants now.
The Second Hospital of Qinhuangdao has 2 studies filed under Fractures, Bone — fewer than ten, so there is no comparison to draw.
1 of the studies in Fractures, Bone with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07063797Peking Union Medical College HospitalStudy on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes | 2027-07-31 |
Add it to your calendar (.ics) → With an account.
Among the 23 studies in Fractures, Bone with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
To introduce a novel external-fixation technique using the combination of K-wires and cement. For comparison, we also included another group of patients who were treated using a mini plate and screw system. Bone healing, range of motion of the fingers, costs of treatments, and patient satisfaction were assessed.
Shaft fractures of the proximal phalanx are common injuries that may significantly affect hand function. Good fracture stability to allow early mobilization of joints and thus early return of function. The objective of this report is to introduce a novel external-fixation technique using the combination of K-wires and cement. For comparison, we also included another group of patients who were treated using a mini plate and screw system. A total of 104 patients (131 fingers) were randomly allocated into group A (56 patients) and B (51 patients). Patients in group A were treated with cemented K-wire fixation; and patients in group B were treated with conventional mini-plate. Bone healing, range of motion of the fingers, costs of treatments, and patient satisfaction were assessed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The mean age of group A was 41 years (range, 18-63 years). There were 56 male and 11 female patients. The mean time from injury to operation was 5±4.53 days. Injured digits included index (n=24), long (n=19), ring (n=9), and little (n=15) fingers. Types of fractures were transversal (n=31), oblique or spiral (n=14), and comminuted (n=22) fractures. The patients were treated with Cemented K-wire Fixation.
Device: Cemented K-wire Fixation · Device: Plating
The mean age of group A was 39 years (range, 19-61 years). There were 51 male and 13 female patients. The mean time from injury to operation was 6±5.53 days. Injured digits included index (n=21), long (n=17), ring (n=10), and little (n=16) fingers. Types of fractures were transversal (n=34), oblique or spiral (n=11), and comminuted (n=19) fractures.The patients were treated with Plating.
Device: Cemented K-wire Fixation · Device: Plating
Fractures were reduced and then fixed with cemented K-wires.
Fractures were reduced and then fixed with Plate.
Bone healing
Time of bone healing.
Time frame: Up to 12 weeks. From date of randomization until the date of first documented progression from any cause, which is assessed up to 12 weeks.
Joint motion
Range of motion of MCP, PIP, and DIP joints.
Time frame: Up to 2 years. From date of randomization until the date of second documented progression from any cause, which is assessed up to 2 years.
Patient satisfaction.
Patient self assessment based on 100-mm visual analogue scale.
Time frame: Up to 2 years. From date of randomization until the date of third documented progression from any cause, which is assessed up to 2 years.
Plan to share: No — No plan to share the IPD data.
Ran from Jan 2011 to primary completion in May 2014, 40 months.
Of 148 non-industry interventional studies with no phase under Fractures, Bone, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 57. This study's 40 months is above that.
Counting every sponsor, half of 166 studies reached it within 29 months; a quarter within 12 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Second Hospital of Qinhuangdao